Actualités Avricore Health Inc - AVCR | Actions TSX Venture Exchange

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF...

Avricore Health Corporate Update: Effective Plan, Resources Result in Success

VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the...

Avricore Health Refocuses Strategy to Unlock Growth Potential

VANCOUVER, British Columbia, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSX-V: AVCR) ("Avricore...

Avricore Health Recognized in Deloitte’s 2024 Technology Fast 50™ Companies to Watch

VANCOUVER, British Columbia, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSX-V: AVCR), a leader...

Avricore Grants Options

VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the...

Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability

VANCOUVER, British Columbia, Aug. 29, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the...

AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY

VANCOUVER, British Columbia, June 03, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the...

Avricore Health Corporate Update and Audited Results for 2023

VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the...

HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations

VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF...

Avricore Health Corporate Update – Company Demonstrates Strong Growth

VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the...

HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic

VANCOUVER, British Columbia, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF...

Avricore Health Corporate Update – Mid-Year Review Demonstrates Company on Right Track

VANCOUVER, British Columbia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the...

HealthTab™ Signs Reseller Agreement With Abbott to Support UK Expansion

VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF...

Avricore’s HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom

VANCOUVER, British Columbia, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF...

HealthTab™ to Integrate CONTOUR®NEXT Family of Blood Glucose Meters to Offer Deeper Diabetes Patient Insights

VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Avricore Health Inc (AVCR)

Outils de qualité professionnelle, pour des investisseurs individuels.

AVCR Actualités

HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK

Avricore Health Corporate Update: Effective Plan, Resources Result in Success

Avricore Health Refocuses Strategy to Unlock Growth Potential

Avricore Health Recognized in Deloitte’s 2024 Technology Fast 50™ Companies to Watch

Avricore Grants Options

Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability

AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY

Avricore Health Corporate Update and Audited Results for 2023

HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations

Avricore Health Corporate Update – Company Demonstrates Strong Growth

HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic

Avricore Health Corporate Update – Mid-Year Review Demonstrates Company on Right Track

HealthTab™ Signs Reseller Agreement With Abbott to Support UK Expansion

Avricore’s HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom

HealthTab™ to Integrate CONTOUR®NEXT Family of Blood Glucose Meters to Offer Deeper Diabetes Patient Insights

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Avricore Health Inc (AVCR) Actualités

Avricore Health Inc (AVCR)

Outils de qualité professionnelle, pour des investisseurs individuels.

AVCR Actualités

HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK

Avricore Health Corporate Update: Effective Plan, Resources Result in Success

Avricore Health Refocuses Strategy to Unlock Growth Potential

Avricore Health Recognized in Deloitte’s 2024 Technology Fast 50™ Companies to Watch

Avricore Grants Options

Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability

AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY

Avricore Health Corporate Update and Audited Results for 2023

HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations

Avricore Health Corporate Update – Company Demonstrates Strong Growth

HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic

Avricore Health Corporate Update – Mid-Year Review Demonstrates Company on Right Track

HealthTab™ Signs Reseller Agreement With Abbott to Support UK Expansion

Avricore’s HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom

HealthTab™ to Integrate CONTOUR®NEXT Family of Blood Glucose Meters to Offer Deeper Diabetes Patient Insights

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités